ClinicalTrials.gg
Not yet recruitingNCT06625866Updated Oct 3, 2024

Evaluation of Interventions Based on Behavioral Sciences to Reduce Episiotomy Use

An interventional study of Feedback and information in Episiotomy, Episiotomy Extended by Laceration and Episiotomy Infection, sponsored by Universidad Panamericana. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-03.

Sponsored by Universidad Panamericana · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This pilot study seeks to analyze the impact of interventions based on behavioral economics theory (e.g., feedback and information) on episiotomy use.

02

Conditions studied

  • Episiotomy
  • Episiotomy Extended by Laceration
  • Episiotomy Infection
  • Episiotomy Wound

Browse trials for

03

In context

Lacerations

174 studies on the registry are indexed under Lacerations; 43 are open to participants now.

This study's planned enrollment of 2 is below the median of 65 across 128 interventional studies indexed under Lacerations.

Browse Lacerations studies →

Lead sponsor

Universidad Panamericana is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthcare personnel involved in decision-making associated with performing episiotomies who work in the hospital selected to pilot the proposed intervention.

Exclusion criteria

Exclusion Criteria:

  • Healthcare personnel who are not involved in the decision-making process over performing episiotomy during delivery.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2 participants (estimated)

Study arms

  • Experimental
    Behavioral intervention

    The healthcare professionals in this hospital will be exposed to behavioral interventions, including feedback and information strategies.

    Behavioral: Feedback and information

  • No intervention
    Standard of care

    The standard of care will be provided in this hospital without exposure to behavioral interventions for healthcare professionals.

Interventions

  • BehavioralFeedback and information

    The healthcare professionals in the intervention arm will be exposed to feedback and information behavioral strategies. Namely, interns, residents, obstetricians/gynecologists, and nurses will receive written feedback about the episiotomy rates in the hospital each month during the study period. Moreover, at least two academic sessions will be designed to outline the indications, surgical technique, complications, and surgical ethics for the procedure (i.e., episiotomy). Likewise, each session will also include a patient testimonial about their experience during delivery and their follow-up when an episiotomy was performed. The feedback intervention will be provided for 2 months, and the feedback intervention + the information intervention will be provided for 2 additional months.

06

What researchers measure

Primary outcomes

  1. Number of episiotomies performed

    Number of episiotomies performed among patients having a vaginal delivery. Episiotomy: surgical incision made in the perineum during childbirth to enlarge the vaginal opening and facilitate the delivery. There are two main types of episiotomies, classified based on the direction of the incision: Median (the incision is made straight down from the vaginal opening towards the anus) and mediolateral (the incision is made at an angle \[usually 45 degrees\] from the vaginal opening towards the side, away from the anus).

    Time frame: During spontaneous or assisted vaginal delivery

Secondary outcomes

  1. Episiotomy indication documented in the medical record

    Number of episiotomies performed with an indication documented in the medical record among patients having a vaginal delivery. Potential indications: Nonreassuring fetal status, prolonged or difficult labor, operative vaginal delivery, shoulder dystocia, large for gestational age fetus, breech delivery, rigid perineum, maternal fatigue or exhaustion, preterm delivery.

    Time frame: During spontaneous or assisted vaginal delivery

  2. Number of assisted vaginal deliveries

    Number of assisted deliveries among patients having a vaginal delivery. Assisted vaginal delivery refers to the use of specialized instruments, such as forceps or a vacuum device, to help guide the fetal head out of the birth canal during childbirth.

    Time frame: At the time of vaginal delivery

  3. Number of perineal and cervical lacerations (composite outcome)

    Number of perineal and cervical lacerations (composite outcome) among patients having a vaginal delivery. The composite outcome will include any of the following: Perineal Lacerations: First degree: Injury to Perineal skin only. Second degree: Injury to perineum involving perineal muscles but not involving anal sphincter. Third degree: Injury to perineum involving anal sphincter complex. 3a: Less than 50% of external anal sphincter thickness torn. 3b: More than 50% external anal sphincter thickness torn. 3c. Both external anal sphincter and internal sphincter torn. Fourth degree: Injury to perineum involving anal sphincter complex (external anal sphincter and internal anal sphincter) and anal epithelium. Cervical Laceration: A cervical laceration during delivery refers to a tear or injury to the cervix that occurs during childbirth.

    Time frame: At the time of spontaneous or assisted vaginal delivery

  4. Rate of transfusion of blood products (composite outcome)

    Administration of any of the following : RBCs, fresh frozen plasma (FFP), platelets and cryoprecipitate

    Time frame: Administered in the first 24 hours after delivery

  5. Blood loss at the time of delivery

    Estimated or calculated blood loss (mL).

    Time frame: Within the first hour after spontaneous or assisted vaginal delivery

  6. Hematocrit after delivery

    Percentage (%) of red blood cells (RBCs) in the total blood volume.

    Time frame: Within 24 hours after delivery

  7. Pain management after delivery

    Description of Nonsteroidal Antiinflammatory Drugs and Opioids administered

    Time frame: Administered in the first 24 hours after vaginal delivery

  8. Patient satisfaction with the inpatient care received during and after vaginal delivery

    Brief voluntary and anonymous survey designed by the research team to be answered by \~300 patients.

    Time frame: Within the first 24 hours after delivery.

  9. Rate of surgical site infection

    Surgical site infection related to episiotomies, perineal, or cervical lacerations that occurred at the site of these surgical or traumatic wounds after childbirth.

    Time frame: In the first 6 weeks after vaginal delivery

  10. Rate of surgical site dehiscence

    Partial or complete wound reopening along a surgical incision or laceration previously closed (e.g., episiotomies, perineal lacerations, cervical lacerations).

    Time frame: In the first 6 weeks after vaginal delivery

  11. Five-minute Apgar

    5-Minute Apgar Score Components: The Apgar score assesses five key signs of a newborn's health, each assigned a score of 0, 1, or 2, for a total possible score of 10: 1. Appearance (skin color) * 0: Blue or pale all over. * 1: Body pink, but extremities blue. * 2: Entire body pink. 2. Pulse (heart rate) * 0: No heartbeat. * 1: Fewer than 100 beats per minute. * 2: At least 100 beats per minute. 3. Grimace (reflex irritability, response to stimulation) * 0: No response to stimulation. * 1: Grimace or weak response when stimulated. * 2: Strong cry or active withdrawal in response to stimulation. 4. Activity (muscle tone) * 0: Limp, no movement. * 1: Some flexion of extremities. * 2: Active movement. 5. Respiration (breathing effort) * 0: Not breathing. * 1: Weak or irregular breathing. * 2: Strong cry, normal breathing.

    Time frame: Neonatal assessment 5 minutes after spontaneous or assisted vaginal delivery

  12. Rate of NICU Admission

    Transfer and care of a newborn in the Neonatal Intensive Care Unit (NICU) to provide intensive medical care for premature, ill, or high-risk newborns.

    Time frame: In the first 24 hours after delivery.

  13. Rate of Neonatal death

    Neonatal death refers to the death of a newborn within the first 28 days of life. This period is further divided into two phases: * Early neonatal death: Neonatal death within the first 7 days of life. * Late neonatal death: Neonatal death occurring between 7 and 28 days of life.

    Time frame: Within the first 28 days of life

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06625866
Lead sponsor
Universidad Panamericana
Collaborators
Universidad de la Salud - UNISA, IMSS-Bienestar, Secretaría de Educación, Ciencia, Tecnología e Innovación de la Ciudad de México
Responsible party
Mario I. Lumbreras-Marquez, MD, MMSc (Professor, Public Health and Epidemiology Department, Universidad Panamericana) — Principal investigator
First posted
Oct 3, 2024
Start date
Oct 2024 (estimated)
Primary completion
Oct 2025 (estimated)
Completion
Oct 2025 (estimated)
Last update
Oct 3, 2024

Study contacts

Mario I Lumbreras-Marquez, MD, MMSc
Contact
mlumbreras@up.edu.mx
+52 55 54821600 ext. 5695

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion